TY - JOUR
T1 - Gastrointestinal symptoms and sensory abnormalities associated with behavioral problems in children with neurodevelopmental disorders
AU - Kurokawa, Shunya
AU - Nomura, Kensuke
AU - Miyaho, Katsuma
AU - Sanada, Kenji
AU - Iwamoto, Chiaki
AU - Naraoka, Minori
AU - Yoneda, Shintaro
AU - Tomizawa, Yoshihiro
AU - Sawae, Yukinori
AU - Iwanaga, Ryuichiro
AU - Mimura, Masaru
AU - Kishimoto, Taishiro
N1 - Funding Information:
SK has received grants and/or speaker's honoraria from Dainippon‐Sumitomo Pharma, Meiji‐Seika Pharma, and Mochida Pharmaceutical within the past 3 years. KS has received speaker's honoraria from Eli Lilly, Dainippon Sumitomo Pharma, and Meiji Seika Pharma. TK has received consultant fees from Dainippon Sumitomo, Novartis, and Otsuka; speaker's honoraria from Banyu, Eli Lilly, Dainippon Sumitomo, Janssen, MSD, Novartis, Otsuka, and Pfizer; and grant support from Takeda, Dainippon‐Sumitomo, and Otsuka. MM has received grants and/or speaker's honoraria from Asahi Kasei Pharma, Astellas Pharmaceutical, Daiichi Sankyo, Dainippon‐Sumitomo Pharma, Eisai, Eli Lilly, Fuji Film RI Pharma, Janssen Pharmaceutical, Kracie, Meiji‐Seika Pharma, Mochida Pharmaceutical, MSD, Novartis Pharma, Ono Yakuhin, Otsuka Pharmaceutical, Pfizer, Shionogi, Takeda Yakuhin, Tanabe Mitsubishi Pharma, and Yoshitomi Yakuhin, and research funding from Nishikawa Sangyo, Otsuka Pharmaceutical, MSD, Meiji‐Seika Pharma, and Shionogi & Co., Ltd., within the past 3 years. The remaining authors have nothing to declare.
Publisher Copyright:
© 2021 International Society for Autism Research and Wiley Periodicals LLC.
PY - 2021/9
Y1 - 2021/9
N2 - Behavioral problems directly affect the quality of life of caregivers and children with autism spectrum disorder (ASD) and/or attention-deficit/hyperactivity disorder (ADHD), and is known to be associated with clinical factors such as gastrointestinal (GI) symptoms, sensory abnormalities, intellectual abilities, and use of medication. However, previous studies have not considered these relationships comprehensively. We conducted a cross-sectional study of 6–12-year-old children with diagnoses of ASD and/or ADHD at two hospitals in Japan. Scores for the aberrant behavior checklist (ABC), autism-spectrum quotient (AQ), and Conners 3, as well as information on daily sleep and exercise, GI symptoms, and Short Sensory Profile, were collected. Each factor was subjected to a correlation analysis to investigate its effect on ABC scores. A stepwise multiple linear regression analysis for the factors with p < 0.05 was performed. Data were obtained from 60 patients with a mean age of 8.3 years; 21 had ASD alone, 18 had ADHD alone, and 21 had ASD + ADHD. The correlation analyses identified six factors associated with ABC severity: (a) methylphenidate use, (b) Conners hyperactivity score, (c) Conners inattention score, (d) AQ score, (e) SSP score, and (f) GI symptom score. The multiple regression showed that “GI symptoms” and “sensory abnormalities” were independently associated with ABC severity. Although further studies are needed to show a causal relationship, appropriate assessment of GI symptoms and sensory abnormalities may help alleviate some problematic behaviors and improve the quality of life of children with neurodevelopmental disorders and their families. Lay summary: Behavioral problems in children with neurodevelopmental disorders are known to be associated with many factors. This study aimed to comprehensively investigate the known factors. We have discovered that “gastrointestinal symptoms” and “sensory abnormalities” were independently associated with Behavioral problems. Our results suggest that it is important for clinicians and caregivers to pay more attention to children's GI symptoms and sensory abnormalities that may not present as obvious symptoms or complaints.
AB - Behavioral problems directly affect the quality of life of caregivers and children with autism spectrum disorder (ASD) and/or attention-deficit/hyperactivity disorder (ADHD), and is known to be associated with clinical factors such as gastrointestinal (GI) symptoms, sensory abnormalities, intellectual abilities, and use of medication. However, previous studies have not considered these relationships comprehensively. We conducted a cross-sectional study of 6–12-year-old children with diagnoses of ASD and/or ADHD at two hospitals in Japan. Scores for the aberrant behavior checklist (ABC), autism-spectrum quotient (AQ), and Conners 3, as well as information on daily sleep and exercise, GI symptoms, and Short Sensory Profile, were collected. Each factor was subjected to a correlation analysis to investigate its effect on ABC scores. A stepwise multiple linear regression analysis for the factors with p < 0.05 was performed. Data were obtained from 60 patients with a mean age of 8.3 years; 21 had ASD alone, 18 had ADHD alone, and 21 had ASD + ADHD. The correlation analyses identified six factors associated with ABC severity: (a) methylphenidate use, (b) Conners hyperactivity score, (c) Conners inattention score, (d) AQ score, (e) SSP score, and (f) GI symptom score. The multiple regression showed that “GI symptoms” and “sensory abnormalities” were independently associated with ABC severity. Although further studies are needed to show a causal relationship, appropriate assessment of GI symptoms and sensory abnormalities may help alleviate some problematic behaviors and improve the quality of life of children with neurodevelopmental disorders and their families. Lay summary: Behavioral problems in children with neurodevelopmental disorders are known to be associated with many factors. This study aimed to comprehensively investigate the known factors. We have discovered that “gastrointestinal symptoms” and “sensory abnormalities” were independently associated with Behavioral problems. Our results suggest that it is important for clinicians and caregivers to pay more attention to children's GI symptoms and sensory abnormalities that may not present as obvious symptoms or complaints.
KW - Autism spectrum disorders
KW - attention-deficit/hyperactivity disorder
KW - behavioral problems
KW - gastrointestinal symptoms
KW - sensory abnormalities
UR - http://www.scopus.com/inward/record.url?scp=85107349740&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85107349740&partnerID=8YFLogxK
U2 - 10.1002/aur.2549
DO - 10.1002/aur.2549
M3 - Article
C2 - 34076345
AN - SCOPUS:85107349740
SN - 1939-3792
VL - 14
SP - 1996
EP - 2001
JO - Autism Research
JF - Autism Research
IS - 9
ER -